Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 8.4× sales vs its 16.0× historical median P/S.
Fair value ≈ $6.27 · price $3.27 today
Undervalued · 48% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
PRISM Mid-Day Movers: Pharmaceuticals and Healthcare Lead Today's Movement.
Moleculin Biotech (NASDAQ: $MBRX) jumped over 2,100% to about $6.11 after a 1‑for‑25 reverse split, with volume above average but shares still below key moving averages, underscoring high volatility and ongoing losses.
Psyence Biomedical (NASDAQ: $PBM) inched up about 3% to $1.58 on light volume and remains well under its 50‑ and 200‑day averages, reflecting cautious sentiment despite its psychedelic‑medicine pipeline.
Other Notable Movers:
New Found Gold Corp. ( $NFGC) up 18%
NKGen Biotech ( $NKGN) up 16%
Permex Petroleum ( $OILCF) down 30%
https://prismmarketview.com/prism-mid-day-movers-pharmaceuticals-and-healthcare-lead-todays-movement/
$OILCF - Permex Petroleum Corp - 10Q - Updated Risk Factors
New risks include limited U.S. trading market affecting liquidity and capital raising, plus heightened foreclosure and bankruptcy risks tied to $4.4M secured debenture obligations. #Risk
https://d-risk.ai/OILCF/10-Q/2025-02-14
